Clinical Trial Update: Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BI 10773 as an add-on to insulin in adults with type 2 diabetes mellitus; results assessing safety and efficacy have been posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 10773
• Insulin (insulin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17